Literature DB >> 6023527

Central and peripheral effects of muscarinic cholinergic blocking agents in man.

E F Domino, G Corssen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 6023527

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


× No keyword cloud information.
  6 in total

1.  The effects of transdermal scopolamine and four dose levels of oral scopolamine (0.15, 0.3, 0.6, and 1.2 mg) upon psychological performance.

Authors:  A C Parrott
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

2.  Paradoxical reaction to intravenous pentobarbital, meperidine and scopolamine.

Authors:  J Hayden; B C Byrd; F L Bunch
Journal:  Anesth Prog       Date:  1974 May-Jun

3.  Effects of scopolamine and nicotine on human rapid information processing performance.

Authors:  K Wesnes; D M Warburton
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

4.  The separate and combined effects of scopolamine and nicotine on human information processing.

Authors:  K Wesnes; A Revell
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

5.  Methoscopolamine inhibition of sleep-related growth hormone secretion. Evidence for a cholinergic secretory mechanism.

Authors:  W B Mendelson; N Sitaram; R J Wyatt; J C Gillin; L S Jacobs
Journal:  J Clin Invest       Date:  1978-06       Impact factor: 14.808

6.  Characterizing the Access of Cholinergic Antagonists to Efferent Synapses in the Inner Ear.

Authors:  Choongheon Lee; Anjali K Sinha; Kenneth Henry; Anqi W Walbaum; Peter A Crooks; Joseph C Holt
Journal:  Front Neurosci       Date:  2021-12-14       Impact factor: 4.677

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.